Contents
Executive Summary
Global Flu Treatment Market
Product Overview
Market Definition
Segmentation
Assumptions and Acronyms
Research Methodology
Research Objectives
Primary Research
Secondary Research
Forecast Model
Market Size Estimation
Average Pricing Analysis
Macro-Economic Indicators
Market Dynamics
Growth Drivers
Restraints
Opportunities
Trends
Correlation & Regression Analysis
Correlation Matrix
Regression Matrix
Recent Developments, Policies & Regulatory Landscape
Risk Analysis
Demand Risk Analysis
Supply Risk Analysis
Global Flu Treatment Market Analysis
Porter's Five Forces Analysis
Threat of New Entrants
Bargaining Power of Suppliers
Threat of Substitutes
Rivalry among Competitors
PEST Analysis
Political
Economic
Social
Technological
Global Flu Treatment Market
Market Size & Forecast, 2020A–2031F
By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Global Flu Treatment Market: Market Segmentation
By Type
Type A, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Type B, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Type C, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
By Medication
Antiviral Drugs, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Antihistamines, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Analgesics, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Others, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
By Route of Administration
Oral, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Parenteral, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
By Distribution Channel
Hospital Pharmacies, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Retail Pharmacies, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Online Pharmacies, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
By End-User
Hospitals, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Specialty Clinics, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Homecare, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Others, By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
By Region
North America: (US and Canada), By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Asia-Pacific: (India, China, Japan, South Korea, Malaysia, Indonesia, Australia, New Zealand, Rest of Asia-Pacific), By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Middle East & Africa: (North Africa, Israel, GCC, South Africa, Rest of Middle East & Africa), By Value (USD Million) 2020–2031F; YoY Growth (%) 2021–2031F
Company Profiles
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
AstraZeneca
GlaxoSmithKline Plc.
Merck & Co. Inc.
Novartis AG
Sun Pharmaceutical Industries Ltd.
Natco Pharma Ltd.
Bayer AG
Pfizer Inc.
Other Prominent Players
Consultant Recommendations
The above segmentations and company profiles are subject to modification based on detailed feasibility analysis conducted for the final report deliverable.
Select License Type